-
1
-
-
0025612647
-
Tubercuosis in India, past. present and future
-
Fox W. Tubercuosis in India, past. present and future, Ind J Tub 1990; 37 : 175-213.
-
(1990)
Ind J Tub
, vol.37
, pp. 175-213
-
-
Fox, W.1
-
2
-
-
0024364436
-
Rifmpicin raw material characteristics and their effect on bioavailability
-
Cavenaghi R. Rifmpicin raw material characteristics and their effect on bioavailability. Bull Int Un A TB Lung Dis 1989; 64 : 36-7.
-
(1989)
Bull Int Un A TB Lung Dis
, vol.64
, pp. 36-37
-
-
Cavenaghi, R.1
-
4
-
-
0024394983
-
Human bioavailability studies
-
Acocella G. Human bioavailability studies. Bull Int Un A TB Lung Dis 1989; 64: 38-40.
-
(1989)
Bull Int Un A TB Lung Dis
, vol.64
, pp. 38-40
-
-
Acocella, G.1
-
5
-
-
0017944237
-
Clinical Pharmacokinetics of rifampicin
-
Acocella G. Clinical Pharmacokinetics of rifampicin. Clin Pharmacokinet 1978; 3 : 108-27.
-
(1978)
Clin Pharmacokinet
, vol.3
, pp. 108-127
-
-
Acocella, G.1
-
6
-
-
0021029934
-
Effect of food on bioavailability of rifampicin
-
Polasa K, Krishnaswamy K. Effect of food on bioavailability of rifampicin. J Clin Pharmacol 1983; 23 : 433-7.
-
(1983)
J Clin Pharmacol
, vol.23
, pp. 433-437
-
-
Polasa, K.1
Krishnaswamy, K.2
-
7
-
-
0028919860
-
Study of effect of concomitant food on bioavailability of rifampicin. isoniazid and pyrazinamide
-
Zent C, Smith P. Study of effect of concomitant food on bioavailability of rifampicin. isoniazid and pyrazinamide. Tubercle Lung Dis 1995; 76 : 109-17.
-
(1995)
Tubercle Lung Dis
, vol.76
, pp. 109-117
-
-
Zent, C.1
Smith, P.2
-
8
-
-
0024618644
-
A study of blood rifampicin concentrations in smoking and non-smoking healthy individuals and in patients with tuberculosis
-
Xie ZY. A study of blood rifampicin concentrations in smoking and non-smoking healthy individuals and in patients with tuberculosis. Chung Hua Chieh Ho Ho Hsi Tsa Chih 1989; 12 : 3-5.
-
(1989)
Chung Hua Chieh Ho Ho Hsi Tsa Chih
, vol.12
, pp. 3-5
-
-
Xie, Z.Y.1
-
10
-
-
0029840906
-
Therapeutic drug monitoring of the antimycobacterial drugs
-
Peloquin CA. Therapeutic drug monitoring of the antimycobacterial drugs. Clinics in Lab Med 1996; 16 : 717-29.
-
(1996)
Clinics in Lab Med
, vol.16
, pp. 717-729
-
-
Peloquin, C.A.1
-
11
-
-
24544448750
-
Pharmacokinetics of antituberculotics in TB patients with AIDS and diarrhea
-
Choudhri S, Hawken M, Gathu S, et al. Pharmacokinetics of antituberculotics in TB patients with AIDS and diarrhea. Amer J Resp Crit Care Med 1996; 153 : A491.
-
(1996)
Amer J Resp Crit Care Med
, vol.153
-
-
Choudhri, S.1
Hawken, M.2
Gathu, S.3
-
13
-
-
0026531077
-
Pharmacokinetic drug interactions with rifampicin
-
Venkatesan K. Pharmacokinetic drug interactions with rifampicin. Clinical Pharmacokinet 1992; 22 : 47-65.
-
(1992)
Clinical Pharmacokinet
, vol.22
, pp. 47-65
-
-
Venkatesan, K.1
-
14
-
-
0016680298
-
Mechanism of inhibitory effect of PAS granules on the absorption of rifampicin : Adsorption of rifampicin by an excipient, bentonite
-
Bowman G, Lundgren, Stjerstorm G. Mechanism of inhibitory effect of PAS granules on the absorption of rifampicin : Adsorption of rifampicin by an excipient, bentonite. Europ J Clin Pharmacol 1975; 8 : 293-9.
-
(1975)
Europ J Clin Pharmacol
, vol.8
, pp. 293-299
-
-
Bowman, G.1
Lundgren2
Stjerstorm, G.3
-
15
-
-
0027530359
-
Effect of pyrazinamide on rifampicin kinetics in patients with tuberculosis
-
Jain A, Mehta VL, Kulshrestha S. Effect of pyrazinamide on rifampicin kinetics in patients with tuberculosis. Tuber Lung Dis 1993; 74 : 87-90.
-
(1993)
Tuber Lung Dis
, vol.74
, pp. 87-90
-
-
Jain, A.1
Mehta, V.L.2
Kulshrestha, S.3
-
17
-
-
0028031172
-
Cliniclly significant drug interactions with antituberculosis agents
-
Grange JM, Winstanley PA, Davies PDO. Cliniclly significant drug interactions with antituberculosis agents. Drug Safety 1994; 11 : 242-51.
-
(1994)
Drug Safety
, vol.11
, pp. 242-251
-
-
Grange, J.M.1
Winstanley, P.A.2
Davies, P.D.O.3
-
23
-
-
0025202620
-
Drug combinations and the bioavailability of rifampicin
-
Fox W. Drug combinations and the bioavailability of rifampicin. Tubercle 1990; 71 : 243-5.
-
(1990)
Tubercle
, vol.71
, pp. 243-245
-
-
Fox, W.1
-
24
-
-
0029840906
-
Therapeutic drug monitoring of the antimycobacterial drugs
-
Peloquin CA. Therapeutic drug monitoring of the antimycobacterial drugs. Clinics in Lab Med 1996; 16 : 717-29.
-
(1996)
Clinics in Lab Med
, vol.16
, pp. 717-729
-
-
Peloquin, C.A.1
-
25
-
-
0029003888
-
Fixed-dose combinations of antituberculous medications to prevent drug resistance
-
Moulding T, Dutt AK, Reichman LB. Fixed-dose combinations of antituberculous medications to prevent drug resistance. Ann Intern Med 1995; 122 : 951-4.
-
(1995)
Ann Intern Med
, vol.122
, pp. 951-954
-
-
Moulding, T.1
Dutt, A.K.2
Reichman, L.B.3
|